News

‘AMD Set To Become TSMC’s 2nd Largest Customer – Apple Car Chip Production Rumored For China’ -WCCF Tech Report

https://wccftech.com/amd-set-to-become-tsmcs-2nd-largest-customer-apple-car-chip-production-rumored-for-china/

byBenzinga Newsdesk

August 18, 2021

1 minute read

AMD Set To Become TSMC’s 2nd Largest Customer – Apple Car Chip Production Rumored For China

Truist Securities Initiates Coverage On Olaplex Hldgs with Buy Rating, Announces Price Target of $35

By Benzinga Newsdesk

Today, 3:23 AM

Truist Securities analyst Bill Chappell initiates coverage on Olaplex Hldgs (NASDAQ:OLPX) with a Buy rating and announces Price Target of $35.

OLPX

News

NextGen Healthcare Investor Issues Bearish Letter On Co., Addresses ‘misleading’ Aug. 26 Press Release

By Bill Haddad

Today, 3:23 AM

Exposes Company's Latest Effort to Deceive Shareholders by Citing Cherry-Picked Excerpts of Emails Between Lance Rosenzweig and Nominating & Governance Committee Chair Morris Panner, a Long-Term Ally of Board

NXGN

Morgan Stanley Maintains Overweight on TransDigm Gr, Lowers Price Target to $765

By Benzinga Newsdesk

Today, 3:23 AM

Morgan Stanley analyst Kristine Liwag maintains TransDigm Gr (NYSE:TDG) with a Overweight and lowers the price target from $801 to $765.

TDG

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $26

By Benzinga Newsdesk

Today, 3:23 AM

SVB Leerink analyst Mani Foroohar maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $29 to $26.

IONS

‘AMD Set To Become TSMC’s 2nd Largest Customer – Apple Car Chip Production Rumored For China’ -WCCF Tech Report

Related Posts

Truist Securities Initiates Coverage On Olaplex Hldgs with Buy Rating, Announces Price Target of $35

NextGen Healthcare Investor Issues Bearish Letter On Co., Addresses ‘misleading’ Aug. 26 Press Release

Morgan Stanley Maintains Overweight on TransDigm Gr, Lowers Price Target to $765

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $26